Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report

Psychedelic substances have experienced a resurgence of clinical interest in recent years, particularly for their promising effects in the treatment of psychiatric disorders such as depression and anxiety. While evidence regarding their role in chronic pain management remains limited, emerging studies suggest potential therapeutic benefits. This case report describes a patient with persistent somatoform pain disorder and recurrent depressive disorder who underwent four sessions of psilocybin-assisted psychotherapy. The intervention was associated with a reduction in the negative impact of pain on daily life, increased pain acceptance, improved quality of life, and reduction in depressive symptoms. These findings contribute to the growing body of literature suggesting that psychedelics, when combined with psychotherapy, may offer a novel and holistic approach to the treatment of chronic pain. Further controlled studies are needed to explore the safety, efficacy, and underlying mechanisms.

Authors

Institutions

Publication Details

Journal
Psychoactives
Published
2025-09-01
DOI
https://doi.org/10.3390/psychoactives4030030
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report

Gabriel Thorens, M Mercier, Daniele Zullino, Louise Penzenstadler et al.
Psychoactives
Psychedelics and Drug Studies
article

Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report

Gabriel Thorens, M Mercier, Daniele Zullino, Louise Penzenstadler, Vasileios Chytas, Federico Seragnoli, Leonice Furtado, Cédric Mabilais, Albert Buchard, Tatiana Aboulafia Brakha
article en

Abstract

Psychedelic substances have experienced a resurgence of clinical interest in recent years, particularly for their promising effects in the treatment of psychiatric disorders such as depression and anxiety. While evidence regarding their role in chronic pain management remains limited, emerging studies suggest potential therapeutic benefits. This case report describes a patient with persistent somatoform pain disorder and recurrent depressive disorder who underwent four sessions of psilocybin-assisted psychotherapy. The intervention was associated with a reduction in the negative impact of pain on daily life, increased pain acceptance, improved quality of life, and reduction in depressive symptoms. These findings contribute to the growing body of literature suggesting that psychedelics, when combined with psychotherapy, may offer a novel and holistic approach to the treatment of chronic pain. Further controlled studies are needed to explore the safety, efficacy, and underlying mechanisms.

PsychoactivesVol. 4(3)
University of Geneva (CH), University Hospital of Geneva (CH), University of Lausanne (CH)
Openalex Percentile: Top 68%
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report — Gabriel Thorens, M Mercier, et al. · Psychoactives (2025) | TGRS Research Map | TGRS